BSECompany Update11h ago · 18 Nov 2026, 09:18 pm

Newspaper publication for Financial Results for quarter and half year ended 30.09.2026

Parmax Pharma Ltd · 540359

✦ AI SummaryResults

Parmax Pharma Ltd has published its financial results for the quarter and half year ended September 30, 2026, in The Financial Express newspaper.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

5188000b-598c-4e20-98c4-e0585a5512f1.pdf

pdf

Download →
View document text
November 18, 2026 The Department of Corporate Services, BSE Limited, Mumbai BSE Script Code: 540359 Dear Sir /Madam, SUB : NEWSPAPER CUTTING U/R 30 OF THE SEBI (LODR) REGULATIONS, 2015 REF : PUBLICATION OF FINANCIAL RESULTS U/R 33 OF THE SEBI (LODR) REGULATIONS, 2015 With respect to above subject, this is to inform the stock exchanges that pursuant to Regulation 30, 33 and 47 read with Part A(12) of Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 and in continuation to our letter dated November 17, 2026 with regard to outcome of board meeting held on that day, please find enclosed a copy of relevant page of the newspaper The Financial Express in English and Financial Express in Gujarati Edition in which the extract of Financial Results for the quarter and half year ended on September 30, 2026 were published for the information of members. Yours faithfully, For Parmax Pharma Limited Umang Gosalia Managing Director DIN: 05153830